Fig. 6.
Classification of 440 patients with aggressive non-Hodgkin lymphoma according to the 2 important independent prognostic factors.
(A,C,E) Overall survival curves; (B,D,F) Progression-free survival curves. Categories included: high nm23-H1 (≥ 18.6 ng/mL) and low nm23-H1 (< 18.6 ng/mL); high sIL-2R (≥ 1019 U/mL) and low sIL-2R (< 1019 U/mL); high LDH (≥) and low LDH (< normal); and high sCD44 (≥ 483 ng/mL) and low sCD44 (≥ 483 ng/mL).